Literature DB >> 14695167

53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage.

Tamara A Mochan1, Monica Venere, Richard A DiTullio, Thanos D Halazonetis.   

Abstract

53BP1 and NFBD1/MDC1 are recruited rapidly to sites of DNA double-strand breaks (DSBs), where they are hypothesized to function downstream of the ataxia-telangiectasia mutated (ATM) checkpoint kinase as "mediators" of DNA DSB signaling. To test this hypothesis, we suppressed 53BP1 and NFBD1/MDC1 expression by small interference RNA and monitored ATM autophosphorylation at Ser(1981) as a marker for ATM activation. Suppression of NFBD1/MDC1 led to decreased ATM activation and phosphorylation of ATM substrates. This phenotype was identical to that observed in cells with defective Nbs1 function and is consistent with recent observations identifying NFBD1/MDC1 as a component of the Mre11-Rad50-Nbs1 protein complex. In cells with wild-type Nbs1, suppression of 53BP1 expression had no effect on ATM activation but was associated with increased recruitment of NFBD1/MDC1 and Nbs1 to sites of DNA breaks, suggesting that decreased 53BP1 function might be compensated for by increased NFBD1/MDC1 and Nbs1 activity. Indeed, in cells with mutant Nbs1, suppression of 53BP1 led to decreased ATM activation and phosphorylation of ATM substrates. We conclude that DNA DSBs activate ATM through at least two independent pathways involving 53BP1 and NFBD1/MDC1-Nbs1, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695167

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  Ruta graveolens extract induces DNA damage pathways and blocks Akt activation to inhibit cancer cell proliferation and survival.

Authors:  Khalda Fadlalla; Angela Watson; Teshome Yehualaeshet; Timothy Turner; Temesgen Samuel
Journal:  Anticancer Res       Date:  2011-01       Impact factor: 2.480

2.  Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway.

Authors:  Risa Kitagawa; Christopher J Bakkenist; Peter J McKinnon; Michael B Kastan
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

3.  TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint.

Authors:  Rachele Cescutti; Simona Negrini; Masaoki Kohzaki; Thanos D Halazonetis
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

4.  ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1.

Authors:  Zhongsheng You; Charly Chahwan; Julie Bailis; Tony Hunter; Paul Russell
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  PTIP regulates 53BP1 and SMC1 at the DNA damage sites.

Authors:  Jiaxue Wu; Marc J Prindle; Gregory R Dressler; Xiaochun Yu
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

6.  Non-problematic risks from low-dose radiation-induced DNA damage clusters.

Authors:  Daniel P Hayes
Journal:  Dose Response       Date:  2008-01-16       Impact factor: 2.658

7.  Competition effect in DNA damage response.

Authors:  Christoph Greubel; Volker Hable; Guido A Drexler; Andreas Hauptner; Steffen Dietzel; Hilmar Strickfaden; Iris Baur; Reiner Krücken; Thomas Cremer; Günther Dollinger; Anna A Friedl
Journal:  Radiat Environ Biophys       Date:  2008-07-23       Impact factor: 1.925

8.  Differential regulation of centrosome integrity by DNA damage response proteins.

Authors:  Rekha Rai; Ashwini Phadnis; Sharda Haralkar; Rajendra A Badwe; Hui Dai; Kaiyi Li; Shiaw-Yih Lin
Journal:  Cell Cycle       Date:  2008-05-14       Impact factor: 4.534

9.  Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage.

Authors:  Yoonsung Kang; Jung-Hee Lee; Nguyen Ngoc Hoan; Hong-Moon Sohn; In-Youb Chang; Ho Jin You
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

10.  53BP1 promotes ATM activity through direct interactions with the MRN complex.

Authors:  Ji-Hoon Lee; Aaron A Goodarzi; Penny A Jeggo; Tanya T Paull
Journal:  EMBO J       Date:  2009-12-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.